Language selection

Search

Patent 2297295 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2297295
(54) English Title: APPARATUS AND METHOD FOR TRANSMYOCARDIAL REVASCULARIZATION BY LASER ABLATION
(54) French Title: APPAREIL ET METHODE DE REVASCULARISATION TRANSMIOCARDIQUE PAR ABLATION AU LASER
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61B 18/20 (2006.01)
  • A61B 17/00 (2006.01)
  • A61B 18/22 (2006.01)
(72) Inventors :
  • CORREIA, JAMES (United States of America)
  • SHIKHMAN, OLEG (United States of America)
  • PACALA, THOMAS J. (United States of America)
  • KOLESA, MICHAEL (United States of America)
  • AZARBARZIN, KURT (United States of America)
(73) Owners :
  • UNITED STATES SURGICAL CORPORATION
  • JAMES CORREIA
  • OLEG SHIKHMAN
  • THOMAS J. PACALA
  • THOMAS J. PACALA
  • MICHAEL KOLESA
  • KURT AZARBARZIN
(71) Applicants :
  • UNITED STATES SURGICAL CORPORATION (United States of America)
  • JAMES CORREIA (United States of America)
  • OLEG SHIKHMAN (United States of America)
  • THOMAS J. PACALA (United States of America)
  • THOMAS J. PACALA (United States of America)
  • MICHAEL KOLESA (United States of America)
  • KURT AZARBARZIN (United States of America)
(74) Agent: MARKS & CLERK
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 1998-07-22
(87) Open to Public Inspection: 1999-02-04
Examination requested: 2000-03-13
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US1998/015139
(87) International Publication Number: US1998015139
(85) National Entry: 2000-01-19

(30) Application Priority Data:
Application No. Country/Territory Date
60/053,362 (United States of America) 1997-07-22

Abstracts

English Abstract


This invention is an apparatus and method for performing transmyocardial
revascularization (TMR) wherein epicardial tissue (52) is pushed aside during
the formation of a channel (60) in the heart wall (50, 54), and substantially
returns to a position coinciding with the channel (60) to act as a channel cap
(53) to reduce bleeding from the channel (60).


French Abstract

Cette invention est un appareil et une méthode de revascularisation transmyocardique (TMR) dans laquelle le tissu épicardique (52) est poussé sur les cotés pendant la formation d'un canal (60) dans la paroi (50, 54) du coeur, et revient sensiblement à une position coïncidant avec le canal (60) afin de faire office de chapeau (53) du canal pour réduire le saignement provenant du canal (60).

Claims

Note: Claims are shown in the official language in which they were submitted.


WHAT IS CLAIMED IS:
1. A method of performing transmyocardial
revascularization, comprising the steps of:
providing a lasing device having a laser ablation
member;
advancing the laser ablation member at a
predetermined distance within the patient's heart tissue to
mechanically pierce the epicardium;
outputting laser energy from said laser ablation
member to ablate heart tissue and create a channel extending
into the patient's ventricle.; and
withdrawing the laser ablation member from the
heart tissue, whereby epicardial tissue pushed aside during
said advancing step substantially returns to a position
coinciding with the channel and acts as a channel cap to
reduce bleeding from the channel.
2. The method according to claim 1, wherein said
laser ablation member comprises an optical fiber.
3. The method according to claim 1, wherein said
step of outputting laser energy further includes
automatically advancing said laser ablation member within
said heart tissue to create said channel.
4. The method according to claim 3, wherein said
laser ablation member is advanced within said heart tissue
to create said channel at a rate coordinated with magnitude
of laser energy generated.
5. The method according to claim 4, wherein. said
rate is further coordinated with a pulsing frequency of said
lasing device.
-17-

6. The method according to claim 1, wherein said
predetermined distance corresponds to a distance extending
into the patient's myocardium, whereby a portion of the
myocardium coinciding with the channel is mechanically
penetrated and forms part of said channel cap subsequent to
formation of said channel.
7. The method according to claim 1, wherein said
predetermined distance is in the range of about 1mm to about
5mm.
8. The method according to claim 1, further
comprising the step of forming a second transmyocardial
channel without applying pressure to the portion of the
epicardium that caps the channel previously created.
9. The method according to claim 1, wherein said
laser ablation member is housed within a handle piece of
said laser ablation device, said laser ablation device
further including means for providing a retracted position
for said laser ablation member in which said laser ablation
member protrudes a given distance from a front surface of
said hand piece, said given distance being substantially
equal to said predetermined distance, said method further
comprising the step of setting said laser ablation member in
the retracted position prior to advancing it against the
epicardium to pierce and penetrate the epicardium, said
front surface acting as a stop to prevent excess penetration
of said laser ablation member.
10. The method according to claim 9, wherein said
laser ablation device further includes a selector to enable
an operator to select said retracted position, and further
including the step of selecting the retracted position prior
to advancing said laser ablation member against the
epicardium.
-18-

11. The method according to claim 10, wherein
said laser ablation device further includes an additional
selector to enable an operator to select a maximum extension
position for said laser ablation member, said method further
comprising the step of selecting said maximum extended
position prior to outputting laser energy, said step of
outputting laser energy being performed until said maximum
extended position is reached wherein laser energy is no
longer generated.
12. The method according to claim 1, wherein said
channel cap is in the form of a flap of heart tissue
defining an annular interface with proximal heart tissue,
said annular interface being less than 360 degrees in
angular extent.
13. A method for performing transmyocardial
revascularization, comprising the steps of:
providing a lacing device having at least one
optical fiber for outputting laser energy, said lacing
device including an indexer for providing a retracted
position for said fiber protruding from a front surface of a
hand piece retaining said fiber;
placing said fiber in the retracted position and
advancing the fiber against the epicardium of a patient
without outputting laser energy therefrom to mechanically
pierce the epicardium;
outputting laser energy from said fiber while
correspondingly advancing the fiber to thereby create a
channel extending into the patient's ventricle; and
withdrawing the fiber from the heart tissue,
whereby epicardial tissue pushed aside by said fiber during
said placing step returns to a position coinciding with the
channel and acts as a channel cap to reduce bleeding from
the channel.
-19-

14. The method according to claim 13, wherein
said step of outputting laser energy from said fiber is
performed while advancing said fiber contemporaneously at a
rate coordinated with magnitude of said laser energy
generated and with a pulsing frequency of said lacing
device.
15. The method according to claim 13, wherein
said retracted position is selected such that said fiber
penetrates the patient's myocardium prior to said front
surface contacting the epicardium, whereby a portion of the
myocardium is pushed aside by the fiber during said placing
step and, upon withdrawal of the fiber, returns to a
position coinciding with the channel to form part of said
channel cap.
16. The method according to claim 13, wherein
said retracted position corresponds to a distance from a
distal surface of said fiber to said front surface of said
hand piece in the range of about 1mm to about 10mm.
17. The method according to claim 13, wherein
said step of placing entails advancing the fiber within the
patient's heart tissue until the front surface of said hand
piece contacts the epicardium.
18. A lacing device, comprising:
a hand piece having proximal and distal ends and a
front surface at said distal end;
a laser ablation member having first and second
ends, the first end being extendible through said hand
piece;
an indexer for placing said laser ablation member
in a stationary retracted position protruding a
predetermined distance from said front surface to enable
said laser ablation member to mechanically penetrate the
-20-

epicardium of a patient;
a laser energy generator optically connected to
the laser ablation member second end; and
an advancing mechanism operably connected to the
laser ablation member for advancing the laser ablation
member through the distal opening of the hand piece.
19. The lasing device according to claim 18,
wherein said indexer includes a limit stop disposed within
said advancing mechanism.
20. The lasing device according to claim 19,
wherein said indexer further includes a selector to allow an
operator to adjust the retracted position.
21. The lasing device according to claim 18,
wherein said advancing mechanism is operable to advance said
laser ablation member at a rate coordinated with magnitude
of laser energy output of said laser generator to ablate
heart tissue.
22. A method of performing transmyocardial
revascularization, comprising the steps of:
providing a lasing device having a laser
ablation member;
advancing the laser ablation member against
the epicardium of a patient to mechanically pierce the
epicardium;
advancing the laser ablation member at a
predetermined rate within the patient's heart tissue as the
laser fires to form a channel; and
withdrawing the laser ablation member from
the heart tissue, whereby epicardial tissue pushed aside
during piercing substantially returns to a position
coinciding with the channel and acts as a channel cap to
reduce bleeding from the channel.
-21-

23. A method of performing transmyocardial
revascularization, comprising the steps of:
providing a lasing device having a laser ablation
member;
advancing the laser ablation member against the
epicardium of a patient to mechanically pierce the
epicardium;
advancing the laser ablation member at a
predetermined rate;
outputting laser energy from said laser ablation
member to ablate heart tissue at a tissue ablation rate
which is slower than said predetermined rate;
decreasing the advancement rate of said laser
ablation member from said predetermined rate to a rate
substantially identical to the tissue ablation rate of said
laser ablation member after said laser ablation member
travels through at least a portion of the epicardium to
create a channel extending into the patient's ventricle; and
withdrawing the laser ablation member from the
heart tissue, whereby epicardial tissue pushed aside during
piercing substantially returns to a position coinciding with
the channel and acts as a channel cap to reduce bleeding
from the channel.
24. A method of performing transmyocardial
revascularization, comprising the steps of:
providing a lasing device having a laser ablation
member;
advancing the laser ablation member against the
epicardium of a patient to mechanically pierce the
epicardium;
advancing the laser ablation member at a
predetermined rate;
outputting laser energy from said laser ablation
member to ablate heart tissue at a tissue ablation which is
slower than said predetermined rate;
-22-

increasing the tissue ablation rate to a rate
substantially identical to the predetermined rate after said
laser ablation member travels through at least a portion of
the epicardium to create a channel into the patient's
ventricle; and
withdrawing the laser ablation member from the heart
tissue, whereby epicardial tissue pushed aside during
piercing substantially returns to a position coinciding with
the channel and acts as a channel cap to reduce bleeding
from the channel.
-23-

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02297295 2000-O1-19
WO 99/04708 PCT/US98/15139
APPARATUS AND METIiOD FOR TRANSMYOCARDIAL
REVASCULARIZATION BY LASER ABLATION
BACKGROUND
Technical Field
The present disclosure relates to improved
apparatus and methods for transmyocardial revascularization
(TMR) by laser ablation with a lasing device.
2. Background of the Related Art
TMR is a procedure for treating heart disease,
wherein multiple channels of small diameter are created in
the heart wall, extending into the ventricle. Such channels
facilitate delivery of blood directly from the ventricle to
oxygen starved areas of the heart. TMR is typically used on
patients with ischemic heart disease, particularly those who
are not candidates for coronary artery bypass or
percutaneous transluminal angioplasty.
During a typical TMR procedure, dozens of channels
are created from the epicardium, through the myocardium and
endocardium and into the ventricle, with each channel being
of sufficiently small diameter such that the end portions of
the channels at the epicardium can be closed by blood
clotting. The channels can be created by employing either a
mechanical coring apparatus or a lasing device. With either
technique, an objective is to produce channels that remain
internally patent in the long term and which do not close up
due to fibrosis and/or scarring.
In early laser myocardial revascularization, a C02
laser was used to produce holes in the heart wall by
transmitting laser energy from the laser to the heart wall.
Typical C02 lasers used for TMR are externally located and
have an articulated support arm for aiming and directing
laser energy through a series of mirrors that reflect the
energy onto the heart wall. Thus, some surgical opening of
_.__._____ _ _-___ ___

CA 02297295 2000-O1-19
WO 99/04708 PCT/US98/15139
the chest wall is required to access the heart muscle. The
entrance wound in the heart can be closed by relatively
brief external pressure while the endocardial and myocardial
layers remain open to permit blood.flow from the ventricle
to the heart muscle.
Less traumatic approaches to laser myocardial
revasculari2ation have been disclosed. These methods
include the use of optical fibers introduced either through
a patient's vasculature or alternatively, directly into the
patient's chest cavity. The intravascular method involves
the direction of laser energy from inside the heart to form
a bore in the heart wall while the other method involves
introduction. of the lasing apparatus through a relatively
small iincision in the patient's chest to access the outer
wall of the heart.
U.S. Patent No. 4,658,817 to Hardy discloses a
method and apparatus for TMR using a laser wherein a hollow
needle having a sharp distal tip is inserted into the
epicardium and a laser beam is focussed through the needle
to create channels. It is stated in the Hardy patent that
this technique eliminates surface bleeding and the need for
suture. However, there is no laser ablation member (e. g.,
optical fiber) that advances through the needle and into the
myocardium contemporaneously with laser energy being
generated.
With current TNfR procedures wherein channels are
formed from the outer heart wall, the technique for stopping
the bleeding from each channel at the epicardium after
channel formation typically entails applying pressure to the
3o opening of~the just-fonr~ed channel. Pressure is typically
applied by the finger of the surgeon or assistant during
open heart surgery, or with a laparoscopic instrument when
the procedure is performed laparoscopically. In either
case, because pressure is applied to each channel opening
for at least several seconds, and it is impractical to begin
forming another channel until the bleeding is stopped from
_2_

CA 02297295 2000-O1-19
WO 99/04708 PC'T/US98/15139
the previous channel, the overall TMR procedure can be
undesirably prolonged by the time expended on applying
pressure to each channel.
Accordingly, a need exists for a TMR procedure
wherein the time spent to stop the blood flow from each of
the individual transmyocardial channels is reduced or
eliminated, thereby increasing the likelihood of success of
each operation.
The present disclosure is directed to methods for
performing transmyocardial revascularization employing a
laser device having a laser ablation member, e.g., one or
more optical fibers. One preferred method includes the
steps of: advancing the laser ablation member a
predetermined distance within the patient's heart tissue to
mechanically pierce the epicardium; then outputting laser
energy from the laser ablation member to ablate heart tissue
and create a patent channel extending into the patient's
2o ventricle; and, withdrawing the laser ablation member from
the heart tissue, whereby epicardial tissue pushed aside
during the initial advancing step substantiall}~ returns to a
position coinciding with the channel and acts as a channel
cap to reduce bleeding from the channel. In an alternative
method, the distal end of the laser fiber is advanced to or
maintained at a position such that it extends distally from
a laser handpiece held by the surgeon; the fiber is caused
to press against the epicardium prior to laser firing,
thereby causing the exterior tissue to "tent". The fiber is
then advanced at a desired rate as the laser fires to form
the channel. In each of the above methods, it is preferable
to advance the laser ablation member at a rate coordinated
with the magnitude of laser energy generated in order to
precisely form each channel.
In another alternative method, the laser fiber can
be placed against the epicardium and initially advanced at a
-3-

CA 02297295 2000-O1-19
WO 99/04708 PCT/US98/15139
rate faster than the tissue ablation rate of the laser. In
this method, the fiber during this stage, will mechanically
pass through the heart tissue. After the fiber travels
though at least a portion of the epicardium, the fiber
advancement rate can be decreased to such a rate that the
laser energy alone ablates the tissue to form the channel.
In yet another alternate method, the fiber can be
advanced at a constant rate while the pulse rate of the
laser is varied to allow mechanical passage of the fiber
through at least a portion of the epicardium. More
specifically, the amount of energy delivered by the laser
fiber can be low, e.g., fewer pulses per second, while
passing through a portion of the epicardium, and increased
thereafter to complete the channel.
Advantageously, with the present methods, the
fiber creates a flap or "channel cape in the epicardial
surface. The interface between the channel cap and the
adjacent epicardial/myocardial tissue defines a very narrow
opening such that blood clotting can occur rapidly at the
interface. Thus, the time expended for applying 'pressure to
the channel opening at the epicardium following each
channel's formation is substantially reduced as compared to
prior art methods. The present method may even allow the
pressure-applying step to be eliminated entirely. In
addition, the pressure of the channel cap may permit larger
channels to be formed, as compared to channels without the
cap, due to the channel cap's ability to moderate or prevent
the flow of blood from the channel.
ERIEF DESCRIPTION OF THE DRAWINGS
Various preferred embodiments are described herein
with reference to the drawings, wherein:
FIG. 1 illustrates a laser ablation device used to
create TNR channels;
-4-

CA 02297295 2000-O1-19 ;
~yG ~~pl7~g PCTIUS98115139
FIG. 2 is a perspective view of the laser ablation
device;
FIG. 3 is a perspective view of the hand piece of
the laser ablation device;
FIG. 4 is an exploded view showing the various
components of the hand piece;
FIG. 5 is a side view of the hand piece having a
fiber extended in proximity to the epicardium;
FIG. 6 is a side view showing piercing of the
epicardium;
FIG. 7 is a side view showing the fiber being
advanced through the myocardium and endocardium;
FIG. 8 is a side view showing-withdrawal of the
fiber from the heart tissue to reveal the channel created
therein;
FIG. 9A is a cross-sectional view of a completed
transmyocardial channel;
FIG. 9B is an end view of the epicardium having a
channel capped by a flap;
FIGS. 10-13 illustrate an alternate method for
performing TMR disclosed herein, where:
FIG. 10 is a side view of the hand piece in
proximity to the epicardium;
FIG. 11 is a side view showing piercing of the
epicardium;
FIG. 12 is a side view showing the fiber being
advanced through the myocardium and endocardium;
FIG. 13 is a side view showing withdrawal of the
fiber from the heart tissue to reveal the channel created
therein;
FIGS. 14-16 illustrate an alternative method for
performing TMR disclosed herein; where:
FIG. 14 is a side view showing piercing of the
epicardium;
FIG. 15 is a side view showing the fiber being
advanced through the myocardium and endocardium;
-5-

CA 02297295 2000-O1-19
WO 99/04708 PCT/US98/15139
FIG. 16 is a side view showing withdrawal of the
fiber from the heart tissue to reveal the channel created
therein;
FIGS. 17-19 illustrate an alternative method for
performing TMR disclosed herein, where:
FIG. 17 is a side view showing piercing of the
epicardium;
FIG. 18 is a side view showing the fiber being
advanced through the myocardium and endocardium; and
l0 FIG. 19 is a side view showing withdrawal of the
fiber from the heart tissue to reveal the channel created
therein.
DETAILED DESCRIPTION OF PREFERRED EI~ODIMENTS
Preferred embodiments of TMR methods will now be
described in detail with reference to the drawings, in which
like reference numerals designate identical or corresponding
elements.
Referring to FIGS. 1 and 2, a laser ablation
device, designated generally as 10, is employed to practice
a TMR procedure in accordance with the present disclosure.
Device 10 is capable of advancing a laser ablation member 18
through heart tissue while concomitantly outputting laser
energy, where the advancement rate is coordinated with the
magnitude of laser energy generated and with the pulsing
frequency of the laser source. This coordination enables
highly patent and precise TMR channels to be created.
Lasing device 10 is similar to lasing devices disclosed in
copending, commonly assigned U.S. Patent Application Serial
No. 08/648,638 to Pacala et al., filed May 13, 1996, the
subject matter of which is incorporated herein by reference.
Laser ablation device 10 includes a hand piece 11,
an optical fiber advancing mechanism 12, a laser generator
14, a foot operated actuator 16, and a control module 17.
The optical fiber advancing mechanism 12 is of the type
capable of precisely transmitting longitudinal motion to
-6-

CA 02297295 2000-O1-19
WO 99/04708 PCT/US98/15139
laser ablation member 18, e.g., an optical fiber, optical
fiber bundle or other laser energy transmission mechanism.
The controlled longitudinal motion can be provided by one or
more motors and preferably by one or more commercially
available stepper motors. The laser generator 14 may be
either a continuous wave laser or a pulsed, high energy
laser, such as, for example, an excimer, C02, Yag or an
alexandrite laser.
The optical fiber advancing mechanism 12 and the
to laser generator 14 are operably connected to foot actuator
16. By depressing foot actuator 16, laser energy is
transmitted through the optical fiber 18 by laser generator
14 while fiber advancing mechanism 12 contemporaneously
advances optical fiber 18 relative to hand piece 11.
Alternately, foot actuator 16 can cause at least partial
advancement of the fiber without transmission of laser
energy, as will be described in greater detail. An
electrical signal from foot actuator 16 actuates control
module 17 which communicates with fiber advancing mechanism
12. Control module 17 is programmable and controls the
. motors or other suitable advancing structure in advancing
mechanism 12 upon actuation of foot actuator 16. Control
module 17 is shown with a receptacle 19 adapted to engage a
terminal of a programmable computer to interface control
module 17 with the computer. As such, instructions required
to operate advancing mechanism 12 can then be stored in
memory within control module 17. A toggle switch 15 may be
provided on the control module 17 to switch from an
operation mode to a test mode. In a particular test mode,
when the foot actuator 16 is acted upon, the flexible
optical fiber is moved sequentially from a retracted
position, to a predetermined extended position, and back to
the retracted position.
Fiber advancing mechanism 12 can be equipped with
two internal limit switches Inot shown). The first limit
switch is activated when the optical fiber 18 is at a

CA 02297295 2000-O1-19
WO 99104708 PCT/US98/15I39
desired retracted position (i.e., a "home" position),
wherein the mechanism that is retracting the fiber is caused
to stop. Optical fiber 18 is in the retracted position
unless foot actuator 16 is depressed or the test mode is
activated. The exact retracted position is selectable by
means of selector 23, e.g., a rotatable knob. One way of
implementing a TMR procedure in accordance with the present
disclosure using laser ablation device 10 is to select the
retracted position as a position in which the distal end of
optical fiber 18 protrudes from the distal end of hand piece
11, the purpose of which is discussed in greater detail,
below.
The second limit switch within unit 12
limits/controls the maximum distance that the optical fiber
can extend from hand piece 11. This limit switch is an
indexes which includes external selector 21. Selector 21 is
provided so that the operator can select the desired maximum
extension of the distal end of the optical fiber from the
handpiece. For example, selector 21 can be in the form of a
rotatable knob that can be set at selectable positions,
wherein each position corresponds to a predetermined maximum
longitudinal position of the optical fiber. When the fiber
reaches the selected maximum position, a limit switch
automatically terninates the fiber's advancement. By way of
example, the operator can select maximum fiber extension
positions so that the distal end of the fiber extends from
the distal end of hand piece 11 from between about 0.5 cm
and about 5.0 cm, with the ability to select in increments
of about 0.25 cm to about 0.5 cm. The maximum extension
position is preferably chosen to be slightly longer than the
heart wall thickness for the particular patient such that
fiber 18 will penetrate into the patient's ventricle. Once
the maximum extended position is reached, output of laser
energy is automatically suspended.
FIG. 3 illustrates a perspective view of the hand
piece ll of laser ablation device 10. Briefly, hand piece
_g_

CA 02297295 2000-O1-19
WU 99/04708 PCT/US98l15139
11 includes housing 20 formed from molded housing half-
sections 20a and 20b. Housing 20 has an elongated body 22
with a comically tapered section 24. Optional locator ring
26 is provided at the distal end of comically tapered
section 24. The front surface 27 is positioned in abutting
relation with the epicardium of a patient directly following
the piercing of the epicardium with the tip of fiber 18
during a TMR procedure. Locator ring 26 facilitates proper
orientation of the hand piece with respect to the heart
tissue. However, locator ring may be eliminated if it is
desired to improve visibility of the epicardium with some
trade-off of stability. Locator ring 26 can be formed
integrally with housing half-sections 20a and 20b or can be
removably fastened to tapered section 24. A ridged surface
28 is formed on an outer wall of housing half-sections 20a
and 20b to facilitate grasping of the device 10.
FIG. 4 illustrates hand piece 11 with housing
half-sections 20a and 20b and the internal components
separated. Housing half-sections 20a and 20b define a
central bore 30, a proximal recess 32, and a distal recess
34. The proximal recess 32 is configured to receive a
swivel connector 36 which is fastened to the optical fiber
casing 38. The swivel connector 36 has an annular flange 40
dimensioned to be received within an increased diameter
section 42 of proximal recess 32 to permit rotation of
housing 20 with respect to optical fiber casing 38.
As shown, the locator ring 26 has a cylindrical
body portion 44 having an annular flange 46 formed at its
proximal end. The cylindrical body portion 44 includes a
central bore 50 and is configured to be received within the
distal recess 34 defined by housing half-sections 20a and
20b. Central bore 50 of cylindrical body portion 44 is
aligned with a central opening 48 formed in the distal end
of the housing 20 and the central bore 30 of housing 20.
Locator ring 26 can either swivel, to allow independent
rotation of the hand piece relative thereto, or be fixed in
_g_

CA 02297295 2000-O1-19
WO 991W708 PC'fNS98/15139
place. The optical fiber 18 is slidably positioned within
central bores 30 and 50 such that it can be advanced through
opening 48 in housing 20. Pins or screws 49 can be used to
fasten the housing half-sections 20a and 20b together to
secure the locator ring 26 and the swivel connector 36 to
the housing 20. If locator ring 26 is eliminated, front
surface 31 of tapered portion 29 can act as the stop which
contacts the patient's outer epicardial surface to prevent
initial penetration of fiber 18 beyond distance Di. This
surface 31 can be buttressed slightly whereby it would form
a small diameter collar that is seated against the
epicardium during the channel formation procedure.
As seen in FIG. 3, the distal end of hand piece 11
corresponds to the front surface 27 of locator ring 26.
Allowing optical fiber 18 to protrude enables the surgeon to
pierce the epicardium with the tip of fiber 18 without
initially firing the laser, such that fiber 18 penetrates a
predetermined distance into the outer heart wall. This
initial penetration of the fiber is stopped at the
predetermined distance by means of the surface 27 contacting
the epicardial wall. The operator then depresses foot
actuator 16 to cause laser energy to be generated and form
the channel. By virtue of the initial penetration without
laser energy output, the transmyocardial channel that is
formed will be "capped" at the epicardium by the outer heart
tissue which is not ablated. This will become more apparent
below.
As an alternative to selecting a protruding
retraction position and utilizing the first surface 27 to
prevent excess initial penetration of fiber 18, the
advancing mechanism 12 (FIG. 1) can be designed in
conjunction with the control unit 17 to activate fiber 18 to
automatically advance longitudinally by the desired
predetermined initial distance without laser energy output.
(This initial distance will be designated hereafter as
distance Di). This~automatic initial advancement can be
-10-

CA 02297295 2000-O1-19
WO 99/04708 PCTNS98/15139
implemented either by activating an additional switch (not
shown) on unit 12 or 17, or it can advance automatically
whenever actuator 16 is initially depressed. In either of
these cases, the above-noted retracted position would
preferably not be adjustable but rather, would be preset to
approximately coincide with the distal surface 27. The
operator would then place the surface 27 directly on the
epicardium and then depress foot actuator 16 (or activate
the additional switch), whereupon the fiber 18 would first
automatically advance the distance Di without laser energy
being generated. Following the initial advance, laser
energy would automatically commence and the fiber
correspondingly advanced to create the TMR channel. In this
embodiment, selector switch 23 would be designed in
conjunction with advancing mechanism 12 to allow selection
of the initial penetration distance Di, not to select the
retracted position.
With either of the above approaches, i.e.,
retracted position protruding by distance Di or automatic
adva.~.=ement to distance Di without laser er_ergy, the
operar.or/surgeon preferably selects the initial penetration
distance Di. (Optionally, this distance could be preset and
not alterable by the operator). Typically,- a healthy heart
has a wall thickness of 10-l5mm. A diseased heart may be as
thick as 40mm (measured from the outer surface of the
epicardium to the inner surface of the endocardium). As
such, the initial penetration distance Di is typically
selected in the range of about 1 to about 2-Smm and
preferably from about 2 to about 5mm so that the fiber 18
penetrates slightly into the myocardium. This will ensure
that an adequate channel cap will be subsequently formed.
The diameter of the fiber (or fiber optic bundle) 18 is
typically in the range of about 0.5 to about 2.5mm, and
preferably about l.4mm. The TMR channel to be formed has
about the same size diameter as the fiber or fiber bundle
18.
-11-

CA 02297295 2000-O1-19
WO 99/Oa708
PCT/US98/15139
In either of the above methods, the heart tissue
may "tent" in response to the partially advanced fiber
pressing against the epicardium. If this occurs, upon
commencement of laser firing, the heart tissue will swiftly
move towards the handpiece (the "tent" will collapse). This
movement of the tissue will cause the outer layers of the
heart tissue to receive less laser energy, resulting in at
least a partial channel cap to aid in closing the channel.
Referring now to FIGS. 5-8, a method for producing
a TMR channel utilizing the laser ablation device 10 is
illustrated. As shown in FIG. 5, hand piece 11 is brought
in proximity to the epicardium 52 of a heart patient. Prior
to entry into the epicardium, the tip of optic fiber 18
protrudes slightly from the locator ring 26 by distance Di,
where Di is measured from the distal surface 18a of fiber 18
to the front surface 27 of locator ring 26. It is noted
that the surface 18a may be flat as shown; however, it could
alternatively be beveled to facilitate piercing of the
epicardium and preliminary advancement into the
2C epicardial/myocardial tissue. In any case, the distance Di
is selectable by means of select switch 23 (FIG. 1)
discussed earlier. with the tip of fiber 18 protruding in
this manner (retracted position), and without depressing the
foot actuator 16 to output laser energy, the fiber tip
surface 18a is brought into contact with epicardium 52 so as
to mechanically pierce or "tent" the epicardial outer
surface. The fiber tip initially advances through at least
a portion of the epicardium 52 and myocardium 50 either
without laser energy being generated or immediately after
lasing begins. As the tip of fiber 18 penetrates,
epicardial tissue (and as shown, myocardial tissue, if
desired) adjacent to the fiber tip is pushed aside. This
pushed aside tissue will not be ablated by the laser energy.
Tissue 53 will substantially return to its natural position
following channel formation and act as a cap to reduce
bleeding from the charnel as will become apparent below.
-12-

CA 02297295 2000-O1-19
WO 99/04708 PCT/US98/15139
In a preferred method, initial penetration of the
fiber occurs until the front surface 27 contacts the
epicardium 52 (FIG. 6). At this point, fiber 18 has
penetrated approximately the distance Di into the heart
tissue. Locator ring 26 enhances the surgeon's ability to
position and stabilize the laser device 10 with respect to
the heart, which can be beating during the procedure.
However, as explained above, some embodiments may not
utilize locator ring 26.
to As depicted in FIG. 7, the TMR channel is formed
by transmitting laser energy from the tip of fiber 1B to
ablate heart tissue while correspondingly advancing optical
fiber 18. The fiber tip is advanced through the myocardium
50 and endocardium 54 until it reaches its maximum extended
position corresponding to the distance D2 between fiber tip
surface 18a and the surface 27 of locator ring 26.
In methods disclosed herein, while forming the
channel below the channel cap, fiber 18 is preferably
advanced at a rate that. is coordinated with the power level
and the frequency of pulsing of the laser generator. For
example, optical fiber 18 can be advanced at a rate. of
between about 0.125mm/sec (0.005 in/sec) to about 12.7mm/sec
(0.5 in/sec) with a laser power level of about 10 mJ/mm2 to
about 60 mJ/mm2 and a pulsing frequency of about 5 Hz to
about 400 Hz. Preferably, the optical fiber is advanced at
a rate of about 0.75mm/sec to about 2.Omm/sec with a laser
power level of between about 30 mJ/mm2 to about 40 mJ/mm2
and a pulse frequency of about 20 to about 50 Hz. In a most
preferred embodiment, the rate of advancement of the optical
fiber is no greater than the rate of ablation of tissue in
order to minimize mechanical tearing by the fiber.
Alternatively, if some degree of mechanical tearing is
desired in addition to laser ablation, the advancing
mechanism can be set to advance the fiber at a rate greater
than the ablation rate. Studies have shown that a xenon
chloride excimer laser operating at a power level of about
-13-

CA 02297295 2000-O1-19
PC'TNS98/15139
35mJ/mm2 can ablate about 30-35 microns of animal heart
tissue per pulse.
As discussed above, the maximum extended position
corresponding to the distance D2 is selectable by the
surgeon by means of select switch 21. Once the maximum
extended position is reached, wherein fiber 18 typically
penetrates slightly into ventricle 56, output of laser
energy is automatically suspended. At this point, the
operator releases depression of foot actuator 16, causing
fiber 18 to retract to the retracted position, as depicted
in FIG. 8. The hand piece 11 is then drawn away from the
heart wall whereby transmyocardial channel 60 is completed.
The completed transmyocardial channel 60 is shown
in cross-section in FIG. 9A, while FIG. 9B shows the end
view, of the epicardium 52. The epicardium/myocardial tissue
53 that was pushed aside without being ablated during the
preliminary penetration of fiber 18, returns to its original
location coinciding with channel 60 upon the fiber's
withdrawal. This tissue 53 forms a flap that acts as a cap
for the channel 60 to reduce bleeding from the channel at
the epicardium 52. The interface 59 between the flap of
tissue 53 and the adjacent tissue is generally an annular
ring less than 360_ in extent. As shown, the cap 53 can
consist of both epicardial and myocardial tissue, but could
alternatively be just epicardial tissue.
Once channel 60 is completed, fiber 18 can be
moved to another location on the epicardium to begin forming
another channel, without the necessity of applying extended
pressure to the portion of the epicardium coinciding with
just-formed channel 60. The overall procedure wherein
dozens of channels 60 are typically formed can thus be
performed much faster as compared to other methods.
Three alternate methods of forming a TMR channel
having a channel cap will now be discussed with reference to
Figs. 10-19. In a first alternative method, the distal end
18a of the laser fiber 18 is initially flush with the distal
-14-

CA 02297295 2000-O1-19
WO 99/04708 PCTNS98I15139
end of laser handpiece 11 (FIG. 10). The fiber 18 is then
caused to puncture the epicardium 52 prior to or upon
commencement of laser firing (FIG. 11) by advancing the
fiber a distance Di prior to firing. The fiber is then
advanced at a specifically desired rate as the laser fires
to form the channel 60 (FIG. 12); and is withdrawn upon
completion of the channel 60 (FIG.13).
In a second alternative method, the laser fiber 18
can be placed against the epicardium 52 and initially
advanced at a rate faster than the tissue ablation rate of
the laser (FIG. 14). In this method, the fiber 18 will
mechanically pass through the heart tissue. After the fiber
18 travels through at least a portion of the epicardium 52,
the fiber advancement rate can be decreased to such a rate
that the laser energy ablates the tissue to form~the channel
60 (FIG. 15). The fiber 18 is then withdrawn from the
heart t;ssue (FIG. 16).
In a third alternative method shown by FIGS. 17
19, the fiber 18 pierces the heart tissue (FIG. 17) and is
advanced at a constant rate while the firing rate of the
laser energy is varied to allow mechanical passage of the
fiber 18 through at least a portion of the epicardium 52
(FIG. 18). More specifically, the amount of energy
delivered by the laser fiber 1B can be low, e.g., fewer
pulses per second, while passing through a portion of the
epicardium 52, and increased thereafter to complete the
channel 60. The fiber 18 is then withdrawn from the heart
tissue (FIG. 19).
It is also contemplated to produce multiple
channel caps in the epicardium sequentially in the same
channel by repetitively and consecutively advancing the
fiber and firing the laser. Multiple channel caps will
provide better assurance that the channel has been
successfully capped.
It will be understood that various modifications
can be made to the embodiments disclosed herein. For
-15-

CA 02297295 2000-O1-19
PCT/US98115139
example, other types of devices for delivering laser energy
could alternatively be used to produce TMR channels
utilizing the method of the present disclosure. For
instance, the method can be performed endoscopically,
wherein the fiber is entroduced through a small tube to
access the heart wall. Therefore, the above description
should not be construed as limiting, but merely as
exemplifications of preferred embodiments. Those skilled in
the art will envision other modifications within the scope
l0 and spirit of the claims appended hereto.
-16-

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC expired 2016-01-01
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Inactive: Dead - No reply to Office letter 2002-04-22
Application Not Reinstated by Deadline 2002-04-22
Inactive: Inventor deleted 2001-09-18
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2001-07-23
Inactive: Status info is complete as of Log entry date 2001-06-01
Inactive: Abandoned - No reply to Office letter 2001-04-23
Letter Sent 2000-03-30
Inactive: Inventor deleted 2000-03-30
Inactive: Cover page published 2000-03-20
Inactive: First IPC assigned 2000-03-16
Request for Examination Requirements Determined Compliant 2000-03-13
Amendment Received - Voluntary Amendment 2000-03-13
Request for Examination Received 2000-03-13
All Requirements for Examination Determined Compliant 2000-03-13
Inactive: Inventor deleted 2000-03-10
Inactive: Inventor deleted 2000-03-10
Inactive: Inventor deleted 2000-03-10
Inactive: Applicant deleted 2000-03-10
Inactive: Applicant deleted 2000-03-10
Inactive: Applicant deleted 2000-03-10
Inactive: Correspondence - Formalities 2000-03-09
Inactive: Courtesy letter - Evidence 2000-03-07
Inactive: Notice - National entry - No RFE 2000-03-01
Application Received - PCT 2000-02-28
Application Published (Open to Public Inspection) 1999-02-04

Abandonment History

Abandonment Date Reason Reinstatement Date
2001-07-23

Maintenance Fee

The last payment was received on 2000-01-19

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
MF (application, 2nd anniv.) - standard 02 2000-07-24 2000-01-19
Basic national fee - standard 2000-01-19
Request for examination - standard 2000-03-13
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
UNITED STATES SURGICAL CORPORATION
JAMES CORREIA
OLEG SHIKHMAN
THOMAS J. PACALA
THOMAS J. PACALA
MICHAEL KOLESA
KURT AZARBARZIN
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column (Temporarily unavailable). To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.

({010=All Documents, 020=As Filed, 030=As Open to Public Inspection, 040=At Issuance, 050=Examination, 060=Incoming Correspondence, 070=Miscellaneous, 080=Outgoing Correspondence, 090=Payment})


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 2000-01-18 1 48
Description 2000-01-18 16 682
Drawings 2000-01-18 9 289
Claims 2000-01-18 7 234
Description 2000-03-12 19 833
Representative drawing 2000-03-19 1 6
Notice of National Entry 2000-02-29 1 195
Acknowledgement of Request for Examination 2000-03-29 1 178
Request for evidence or missing transfer 2001-01-21 1 109
Courtesy - Abandonment Letter (Office letter) 2001-05-27 1 171
Courtesy - Abandonment Letter (Maintenance Fee) 2001-08-19 1 185
Correspondence 2000-02-29 1 16
PCT 2000-01-18 6 231
Correspondence 2000-03-08 1 44